Targeted News Service

Johnson & Johnson Reinforces Its Leadership in Hematology at ASH 2025 Unveiling New Paradigm-shifting Research
November 05, 2025

RARITAN, New Jersey, Nov. 5 -- Johnson and Johnson Innovative Medicine issued the following news release on Nov. 4, 2025:

* * *

Johnson & Johnson reinforces its leadership in hematology at ASH 2025 unveiling new paradigm-shifting research

More than 60 abstracts spotlight leading portfolio and pipeline of innovative medicines in multiple myeloma, lymphoma, leukemia and other blood disorders

*

Johnson & Johnson (NYSE: JNJ), a . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form